Coronary Artery Bypass: Clinical Trials

12 trials for Coronary Artery Bypass, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 terminated, 1 unknown. 12 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 212Completed 7, Terminated 4, Unknown 1
Phase 11Completed 1

Follow Coronary Artery Bypass: new trials by email Literature Review of Coronary Artery Bypass trials Research Report on Coronary Artery Bypass

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
Colchicine - Coronary Artery Disease, Acute Coronary Syndrome
Phase 2CompletedUniversity of Sao Paulo General Hospital1002022-02-052026-03-03
Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting
Roxadustat, Placebo - Coronary Artery Bypass
Phase 2TerminatedPeking Union Medical College Hospital982021-09-302025-12-09
Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery
5-Aminolevulinic Acid hydrochloride (5-ALA), Placebo, Sodium ferrous citrate (SFC) - Cardiac Surgical Procedures, Coronary Artery Bypass
Phase 2CompletedUniversity of Oxford482021-02-012025-06-25
Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass
Nitric Oxide, Standard CPB - Coronary Artery Disease, Coronary Artery Bypass
Phase 1 / Phase 2CompletedTomsk National Research Medical Center of the Russian Academy of Sciences602015-05-152026-10-21
Thiamine as an Adjunctive Therapy in Cardiac Surgery
Thiamine, Normal saline solution - Coronary Artery Bypass, Cardiac Surgical Procedures
Phase 2CompletedBeth Israel Deaconess Medical Center642015-01-012017-03-30
Remote Ischemic Conditioning to Attenuate Myocardial Death and Improve Operative Outcome.
Remote Ischemic Preconditioning with Postconditioning, Sham RIPC procedure - Coronary Artery Bypass, Myocardial Reperfusion Injur
Phase 2UnknownMedinet Heart Centre802014-01-012017-12-06
An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
AP214, Placebo - Cardiac Surgery, Coronary Artery Bypass
Phase 2CompletedAction Pharma A/S772010-10-012012-03-15
Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
Antithrombin III - Acquired Antithrombin III Deficiency, Coronary Artery Bypass
Phase 2CompletedInstituto Grifols, S.A.2002009-06-012016-09-20
Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)
AVI-5126 - Cardiovascular Disease, Coronary Artery Bypass
Phase 2TerminatedSarepta Therapeutics, Inc.6002007-03-012009-07-08
A Retrospective Analysis of the Predictive Potential of Pre-operative
Atrial Fibrillation - Coronary Artery Bypass
Phase 2TerminatedEmory University6002006-02-012013-09-27
Training Intensity After Coronary Bypass Grafting
Exercise training - Coronary Artery Bypass
Phase 2TerminatedNorwegian University of Science and Technology602004-03-012010-05-18
CABG Without the Use of CPB
Coronary artery bypass - Coronary Artery Bypass
Phase 2CompletedMelbourne Health2001-02-012015-07-16

Narrower conditions

Acute Kidney Injury (2)  ·  Coronary Artery Disease (2)  ·  Acute Coronary Syndrome (1)  ·  Aortic Aneurysm (1)  ·  Aortic Valve Disease (1)  ·  Atherosclerosis (1)  ·  Atrial Fibrillation (1)  ·  Cardiovascular Diseases (1)  ·  Kidney Diseases (1)  ·  Myocardial Reperfusion Injury (1)  ·  Postpericardiotomy Syndrome (1)  ·  Reperfusion Injury (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Heart Diseases (4)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Vascular Diseases (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Coronary Disease (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Male Urogenital Diseases (2)  ·  Myocardial Ischemia (2)  ·  Postoperative Complications (2)  ·  Renal Insufficiency (2)  ·  Urogenital Diseases (2)

Interventions

AVI-5126 (1)  ·  Aminolevulinic Acid (1)  ·  Antithrombin III (1)  ·  Cardiopulmonary Bypass (1)  ·  Colchicine (1)  ·  Coronary Artery Bypass (1)  ·  Exercise (1)  ·  Nitric Oxide (1)  ·  Saline Solution (1)  ·  Thiamine (1)  ·  ferrous citrate (1)  ·  roxadustat (1)

Sponsors

Action Pharma A/S (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Emory University (1)  ·  Instituto Grifols, S.A. (1)  ·  Medinet Heart Centre (1)  ·  Melbourne Health (1)  ·  Norwegian University of Science and Technology (1)  ·  Peking Union Medical College Hospital (1)  ·  Sarepta Therapeutics, Inc. (1)  ·  Tomsk National Research Medical Center of the Russian Academy of Sciences (1)  ·  University of Oxford (1)  ·  University of Sao Paulo General Hospital (1)

Countries

United States (2)  ·  Brazil (1)  ·  China (1)  ·  Denmark (1)  ·  Italy (1)  ·  Norway (1)  ·  Poland (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Arash Yavari, DPhil MRCP (1)  ·  Jakub S. Marczak, M.D. (1)  ·  Marco Ranucci, MD (1)  ·  Michael W Donnino, M.D. (1)  ·  Qi Miao, Doctor (1)  ·  Samuel C. Dudley, Jr., MD, PhD (1)  ·  Sergey V Popov, MD (1)  ·  Stephen Davis, MD (1)  ·  Trine T Moholdt, MS (1)  ·  Yan Qin, Doctor (1)

Results publications

PMID 23102903, PMID 27044557